DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
von Minckwitz G, Procter M, de Azambuja E. et al. APHINITY Steering Committee and Investigators.
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer.
N Engl J Med 2017;
377: 122-131
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.